| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |